BlackRock Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.61M Buy
32,877
+9,608
+41% +$444K ﹤0.01% 1905
2016
Q3
$1.11M Buy
23,269
+1,963
+9% +$97K ﹤0.01% 1974
2016
Q2
$1.14M Buy
21,306
+977
+5% +$46K ﹤0.01% 1903
2016
Q1
$909K Buy
20,329
+2,881
+17% +$117K ﹤0.01% 1981
2015
Q4
$666K Sell
17,448
-2,354
-12% -$90K ﹤0.01% 2087
2015
Q3
$630K Buy
19,802
+1,209
+7% +$42.2K ﹤0.01% 2107
2015
Q2
$614K Buy
18,593
+2,069
+13% +$73.8K ﹤0.01% 2185
2015
Q1
$680K Sell
16,524
-274
-2% -$11.1K ﹤0.01% 2064
2014
Q4
$685K Sell
16,798
-12,443
-43% -$486K ﹤0.01% 2101
2014
Q3
$1.07M Sell
29,241
-3,996
-12% -$173K ﹤0.01% 1739
2014
Q2
$1.54M Buy
33,237
+25,375
+323% +$1.13M ﹤0.01% 1598
2014
Q1
$323K Sell
7,862
-1,533
-16% -$57K ﹤0.01% 2354
2013
Q4
$359K Buy
9,395
+3,089
+49% +$95.3K ﹤0.01% 2301
2013
Q3
$151K Buy
+6,306
New +$142K ﹤0.01% 2541

Other funds holding ANIK